| Dr Derek Von Haag, MD | |
|
4892 N Stone Ave, Suite 100, Tucson, AZ 85704-5761 | |
| (520) 396-1370 | |
| (520) 396-1375 |
| Full Name | Dr Derek Von Haag |
|---|---|
| Gender | Male |
| Speciality | Cardiac Surgery |
| Experience | 28 Years |
| Location | 4892 N Stone Ave, Tucson, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073507026 | NPI | - | NPPES |
| 867898 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 32835 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yuma Regional Medical Center | Yuma, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yuma Regional Medical Center | 2062314826 | 288 |
News Archive
A new study led by Dr. Robert Koenekoop at the Montreal Children's Hospital at the McGill University Health Centre holds promise for certain patients with Leber congenital amaurosis, an inherited retinal degenerative disease that causes significant vision loss from birth. The study, sponsored by Canadian company QLT Inc., is designed to treat patients with LCA due to genetic mutations in either retinal pigment epithelium protein 65 or lecithin:retinol acyltransferase.
Flexible Stenting Solutions, Inc., a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has extended its CE Mark authorized family of peripheral vascular stents to include the FlexStent Iliac Self Expanding Stent System.
Celerus Diagnostics, developer of the Wave RPD System and global leader in rapid immunohistochemistry for cancer diagnosis, announced today that the Company has been issued three important patents by the United States Patent and Trademark Office.
The study, published in the British Journal of Clinical Pharmacology, also revealed that 88 pharmacist interventions reduced the length of patient stays in hospital and 156 interventions reduced the potential for the patient to be readmitted to hospital.
› Verified 3 days ago
| Entity Name | Yuma Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194706655 PECOS PAC ID: 2062314826 Enrollment ID: O20040122000526 |
News Archive
A new study led by Dr. Robert Koenekoop at the Montreal Children's Hospital at the McGill University Health Centre holds promise for certain patients with Leber congenital amaurosis, an inherited retinal degenerative disease that causes significant vision loss from birth. The study, sponsored by Canadian company QLT Inc., is designed to treat patients with LCA due to genetic mutations in either retinal pigment epithelium protein 65 or lecithin:retinol acyltransferase.
Flexible Stenting Solutions, Inc., a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has extended its CE Mark authorized family of peripheral vascular stents to include the FlexStent Iliac Self Expanding Stent System.
Celerus Diagnostics, developer of the Wave RPD System and global leader in rapid immunohistochemistry for cancer diagnosis, announced today that the Company has been issued three important patents by the United States Patent and Trademark Office.
The study, published in the British Journal of Clinical Pharmacology, also revealed that 88 pharmacist interventions reduced the length of patient stays in hospital and 156 interventions reduced the potential for the patient to be readmitted to hospital.
› Verified 3 days ago
| Entity Name | Northwest Allied Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003833179 PECOS PAC ID: 7618972514 Enrollment ID: O20060928000110 |
News Archive
A new study led by Dr. Robert Koenekoop at the Montreal Children's Hospital at the McGill University Health Centre holds promise for certain patients with Leber congenital amaurosis, an inherited retinal degenerative disease that causes significant vision loss from birth. The study, sponsored by Canadian company QLT Inc., is designed to treat patients with LCA due to genetic mutations in either retinal pigment epithelium protein 65 or lecithin:retinol acyltransferase.
Flexible Stenting Solutions, Inc., a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has extended its CE Mark authorized family of peripheral vascular stents to include the FlexStent Iliac Self Expanding Stent System.
Celerus Diagnostics, developer of the Wave RPD System and global leader in rapid immunohistochemistry for cancer diagnosis, announced today that the Company has been issued three important patents by the United States Patent and Trademark Office.
The study, published in the British Journal of Clinical Pharmacology, also revealed that 88 pharmacist interventions reduced the length of patient stays in hospital and 156 interventions reduced the potential for the patient to be readmitted to hospital.
› Verified 3 days ago
| Entity Name | Tucson Physician Group Holdings Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356726939 PECOS PAC ID: 0547560070 Enrollment ID: O20151204001261 |
News Archive
A new study led by Dr. Robert Koenekoop at the Montreal Children's Hospital at the McGill University Health Centre holds promise for certain patients with Leber congenital amaurosis, an inherited retinal degenerative disease that causes significant vision loss from birth. The study, sponsored by Canadian company QLT Inc., is designed to treat patients with LCA due to genetic mutations in either retinal pigment epithelium protein 65 or lecithin:retinol acyltransferase.
Flexible Stenting Solutions, Inc., a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has extended its CE Mark authorized family of peripheral vascular stents to include the FlexStent Iliac Self Expanding Stent System.
Celerus Diagnostics, developer of the Wave RPD System and global leader in rapid immunohistochemistry for cancer diagnosis, announced today that the Company has been issued three important patents by the United States Patent and Trademark Office.
The study, published in the British Journal of Clinical Pharmacology, also revealed that 88 pharmacist interventions reduced the length of patient stays in hospital and 156 interventions reduced the potential for the patient to be readmitted to hospital.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Derek Von Haag, MD 2202 N Forbes Blvd, Tucson, AZ 85745-1412 Ph: (520) 396-1370 | Dr Derek Von Haag, MD 4892 N Stone Ave, Suite 100, Tucson, AZ 85704-5761 Ph: (520) 396-1370 |
News Archive
A new study led by Dr. Robert Koenekoop at the Montreal Children's Hospital at the McGill University Health Centre holds promise for certain patients with Leber congenital amaurosis, an inherited retinal degenerative disease that causes significant vision loss from birth. The study, sponsored by Canadian company QLT Inc., is designed to treat patients with LCA due to genetic mutations in either retinal pigment epithelium protein 65 or lecithin:retinol acyltransferase.
Flexible Stenting Solutions, Inc., a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has extended its CE Mark authorized family of peripheral vascular stents to include the FlexStent Iliac Self Expanding Stent System.
Celerus Diagnostics, developer of the Wave RPD System and global leader in rapid immunohistochemistry for cancer diagnosis, announced today that the Company has been issued three important patents by the United States Patent and Trademark Office.
The study, published in the British Journal of Clinical Pharmacology, also revealed that 88 pharmacist interventions reduced the length of patient stays in hospital and 156 interventions reduced the potential for the patient to be readmitted to hospital.
› Verified 3 days ago
Rammohan Marla, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 2055 W Hospital Dr Ste 205, Tucson, AZ 85704 Phone: 520-575-6944 Fax: 520-575-1115 | |
Raj K Bose, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 2404 E River Rd, Bld.2, Ste 100, Tucson, AZ 85718 Phone: 520-696-4780 Fax: 520-408-1847 | |
Dr. Burt Solomon Strug, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 2801 N. Camino Principal, Tucson, AZ 85715 Phone: 520-298-6761 Fax: 520-298-6742 | |
Dr. Christopher Bernard Komanapalli, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 2404 E River Rd Ste 100, Tucson, AZ 85718 Phone: 520-838-3540 Fax: 520-325-3526 | |
Dr. Toshinobu Kazui, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1501 N Campbell Ave, Tucson, AZ 85724 Phone: 520-626-7806 Fax: 520-626-4042 | |
Kenneth A. Fox, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1501 N Campbell Ave, Tucson, AZ 85724 Phone: 520-626-9752 |